Over 1.8 million nonprofits and charities for donors, volunteers and funders

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Volunteering Oportunities

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

130 Stories from Volunteers, Donors & Supporters

Donor

Rating: 5

MAPS keep surprising year after year, steadily advancing knowledge in one of neurocscience's most promising frontiers. Simply awesome. Support their work now!

Previous Stories
10

Professional with expertise in this field

Rating: 5

MAPS is way beyond regular non-profits It's work is on the frontier of medical and neuroscientific research, and I firmly believe they're gonna be responsible for great and important positive changes in the near future, creating new therapeutic tools and helping in changing the current paradigms!

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

I discovered MAPS through their table at a Transpersonal Psychology Association conference many years ago, and by hearing Rick Doblin speak at that conference. I became a MAPS member, and I have since heard Mr. Doblin speak many times. One of the things that immediately impressed me about him was his suggestion that those interested in promoting the benefits of psychedelic substances need also to address the risks of their use. MAPS does this by providing psychedelic crises support at large festivals such as Burning Man, and by providing an immensely valuable online resource, Responding to Difficult Psychedelic Experiences (http://www.maps.org/responding_to_difficult_psychedelic_experiences.html), for helping people undergoing adverse reactions to psychedelic experiences. And of course MAPS tirelessly advocates for government-sanctioned clinical and empirical research into the benefits and risks of psychedelic substances. One particular example of how being a MAPS member has benefited me: When I was working on my dissertation on a Jungian framework for understanding psychedelic experience, I read an article in the MAPS Bulletin about an important British pioneer in LSD therapy, Dr. Ronald Sandison. I was delighted to learn that Dr. Sandison was alive and well at 92, and before long I was talking with him on the telephone and acquiring valuable information for my dissertation. I later had the honor of meeting him in his home in England. None of this would have happened without MAPS.

Review from Guidestar

6

Professional with expertise in this field

Rating: 5

It's never easy being on the cutting edge of scientific development, especially when that edge invites controversy. That usually makes you mostly a target. MAPS faces the challenges with dignity, integrity and with a degree of uncompromising intellectual honesty that has been awarded with measurable results, scientific recognition and growing influence. They need to be supported to be able to do more and to do so at a increased rate so to shorten the suffering of the PTSD sufferers who have yet to find relief.

Review from Guidestar

6

Professional with expertise in this field

Rating: 5

It would be hard to overstate the "wealth of purpose" of this noble organization. As a serious, scientific and legal advocate for research along the neuro-chemical frontiers of the brain and world, MAPS provides both actual service (publications, research-support, conferences, socio-scientific connection) with the virtually infinite therapeutic promise for the future of neurology and the human species as well. James Winchell, Ph.D., Whitman College

Review from Guidestar

8

Professional with expertise in this field

Rating: 5

MAPS is a nonprofit that is deeply committed to research and healing potentials. They are providing an incredible service to all people who are interested in healing.

Review from Guidestar

8

Professional with expertise in this field

Rating: 5

It was unlikely weather for the month of April on the coast of Northern California. The kind of -just the right temperature- clear beautiful light blue skies, and the sun that bathed us just enough to experience what I call the “shower of warmth.” As we drove up the beautiful coast of California heading from our home in Woodland Hills to San Jose to attend the “Psychedelic Science in the 21st Century” conference, I thought of the diversity of my so many interests and activities and the years I have shared these activities with my husband, Oren, who not only supports my choices but rather enjoys the quality of living they add to our lives. The conference was the first of its kind in the last 40 years and I was excited to be part of such highly accredited and intelligent Academia people from scientists to psychologists, psychiatrists, medical field professionals, and great thinkers and practitioners of health from all over the world. As I flipped the first page of the program designed by MAPS (The Multidisciplinary Association for Psychedelic Studies) I read the organization’s mission: 1.To treat conditions for which conventional medicines provide limited relief- such as posttraumatic stress disorder (PTSD), pain, drug dependence, anxiety and depression associated with end-of-life issues- by developing psychedelics and marijuana into prescription medicines. 2.To cure many thousands of people by building a network of clinics where treatments can be provided. 3.To educate the public honestly about the risks and benefits of psychedelics and marijuana. I thought to myself, what is it in this statement that attracts me and excites me to belong? What are the commonalities I find that between me and those 1,000 strangers that feel like family to me. And the answer is: Truth. I eagerly ran from lecture to lecture excited to learn. I received vast amounts of information on how, with proper use, healing with plants and chemicals can be used as a therapeutic guidance. Those substances are tools that operate the technology of the mind. Just like the techniques in NLP (Neuro Linguistic Programming), Time Line Therapy, and Hypnosis. What’s common between those doctors and myself is that we are truth seekers and we all believe that the mind has capabilities of healing everything whether physical, mental, emotional, or spiritual, but thanks to technological advancements we now can prove it. Once again, as many times before in my journey towards understanding the relationship of man between the Universe, himself, and others, I found myself listening to various people from many walks of life saying basically the same statement: “ We are one with all that exists. We are affecting and affected by everything in our environment…internally and externally.” This was not just another conference for me. The content of the conference was interesting, I collected new information that developed my thinking and skills, I asked deep, strong questions and got educated in an area that affects me not only as a coach but as a member of the human family, I got numerous confirmations to my own theory that the mind is an inner technological device, the highest technological device that can be found on the planet and that we are using just a fraction of its potential and that there are ways and techniques that we must LEARN in order to use its full potential. But that was not all that I got - most touching to me is that I got hope, and great positive excitement that the human family is seeking truth, the human family is seeking peace, and health, and caring for one another and to belong to such company was an honor that filled my heart.

Review from Guidestar

4

Professional with expertise in this field

Rating: 5

This organization is the culmination of a 20 year struggle by pioneers in the use and understanding of psychedelics to bring together biochemists, physicians, and lay voyagers in support of furthering our understanding of these astounding and absolutely unique drugs.

Review from Guidestar

9

Professional with expertise in this field

Rating: 5

MAPS is continuing to help shine the light of scientific research on psychedelics. After decades of of governmental clampdown, MAPS has thoughtfully and systematically pursued promoting and funding important research about human consciousness and its alteration by certain substances.

Review from Guidestar

7

Professional with expertise in this field

Rating: 4

As a specialist in public health, I see many opportunities for using psychedelic substances in a medical context. It can be useful for many pathologies for a low cost and very interresting results. But we have it is important to be careful about the way we chose to introduce these powerful drugs in psychotherapy.

Review from Guidestar

8

Professional with expertise in this field

Rating: 5

MAPS is perhaps one of the bravest and most determined non-profit organizations that I've ever come across. They realize that there is real medical and psychological value to the controlled use of psychedelics, and they work hard to let people know about it. Not only are they healing people in their clinical trials, they are also fighting a pernicious stigma every step of the way. MAPS deserves your support for the betterment of the individual patient and for the betterment of society as a whole.

Review from Guidestar